Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction

Publisher： John Wiley & Sons Inc

E-ISSN： 2157-6580|7|2|161-167

ISSN： 2157-6564

Source： STEM CELLS Translational Medicine, Vol.7, Iss.2, 2018-02, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy

By  

STEM CELLS Translational Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 11-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy

By Turinetto Valentina   Vitale Emanuela   Giachino Claudia  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1164-1164

MDPI

Access to resources Recommend Favorite

Attenuating Hypoxia-Induced Apoptosis and Autophagy of Mesenchymal Stem Cells: the Potential of Sitagliptin in Stem Cell-Based Therapy

By  

Cellular Physiology and Biochemistry, Vol. 37, Iss. 5, 2015-0 ,pp. : 1914-1926

Karger

Access to resources Recommend Favorite

Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action

By Shin Tae-Hoon   Kim Hyung-Sik   Choi Soon Won   Kang Kyung-Sun  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 244-244

MDPI

Access to resources Recommend Favorite

Combination therapy with human umbilical cord mesenchymal stem cells and angiotensin‐converting enzyme 2 is superior for the treatment of acute lung ischemia–reperfusion injury in rats

By  

CELL BIOCHEMISTRY AND FUNCTION (ELECTRONIC), Vol. 33, Iss. 3, 2015-04 ,pp. : 113-120

John Wiley & Sons Inc

Access to resources Recommend Favorite